ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Services Research"

  • Abstract Number: 2430 • ACR Convergence 2023

    Time-Dependent Evaluation of Weighted Cumulative Glucocorticoid Exposure and Major Adverse Cardiovascular Events in a Cohort of Veterans with Rheumatoid Arthritis

    Beth Wallace1, Yuqing Gao2, H. Myra Kim1, Bryant England3, Joshua Baker4, Brian Sauer5, Grant Cannon6, Punyasha Roul3, Ted R Mikuls7, Shirley Cohen-Mekelburg1, Daniel Clauw8, Wyndy Wiitala2, Rodney Hayward1, Jeremy Sussman1 and Akbar Waljee9, 1VA Ann Arbor; University of Michigan, Ann Arbor, MI, 2VA Ann Arbor, Ann Arbor, MI, 3University of Nebraska Medical Center, Omaha, NE, 4University of Pennsylvania, Philadelphia, PA, 5Salt Lake City VA/University of Utah, Salt Lake City, UT, 6University of Utah and Salt Lake City VA, Salt Lake City, UT, 7Division of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE, 8Department of Anesthesiology, University of Michigan, Ann Arbor, MI, 9VA Ann Arbor, University of Michigan, Ann Arbor, MI

    Background/Purpose: Three-quarters of RA patients use glucocorticoids (GC) to manage RA symptoms. Prior work suggests recent GC use is associated with major adverse cardiovascular events…
  • Abstract Number: 0163 • ACR Convergence 2023

    Uncovering Discrepancies: Analysis of Glucocorticoid Exposure Among Patients with Rheumatoid Arthritis in Electronic Health Record Data versus Medicare Claims

    Jing Li1, Julia Kay1, Sharon Abada1, Andriko Palmowski2, Rachael Stovall1, Jinoos Yazdany3 and Gabriela Schmajuk4, 1University of California San Francisco, San Francisco, CA, 2Charité - Universitätsmedizin Berlin, Berlin, Germany, 3University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA, 4UCSF / SFVA, San Francisco, CA

    Background/Purpose: Understanding glucocorticoid (GC) exposure is critical for observational analyses in rheumatology. However, obtaining an accurate measure of GC exposure, including dosage and duration, has…
  • Abstract Number: 0465 • ACR Convergence 2023

    The Effects of Post-Dobbs Abortion Policy on Rheumatology Clinical Practice: A Survey of Rheumatologists

    Mehret Birru Talabi1, Bonnie Bermas2, Irene Blanco3, Ashira Blazer4, Megan Clowse5, Cuoghi Edens6, Leslie Pierce7, Catherine Wright1 and Rosalind Ramsey-Goldman3, 1University of Pittsburgh, Pittsburgh, PA, 2UT Southwestern, Dallas, TX, 3Northwestern University, Chicago, IL, 4Hospital for Special Surgery, New York, NY, 5Duke University, Chapel Hill, NC, 6University of Chicago, Chicago, IL, 7University of Pittsburgh, Raleigh, NC

    Background/Purpose: In June 2022, the U.S. Supreme Court's decision in Dobbs v. Jackson Women's Health removed the federal constitutional right to abortion, returning abortion policy…
  • Abstract Number: 1013 • ACR Convergence 2023

    Implementation of a Rheumatology-Based Social Determinants of Health Screening Program to Uncover and Address Needs in a Multihospital Health Care System

    Candace Feldman1, Rebecca Summit1, Karli Retzel1, Haelynn Gim2, Leah Santacroce1, Shalina Patel1, Sarah Wilkie3, Virginia Bills1, Siobhan Case1, Caitlyn Wasserman3, Derrick Todd1, Nancy Sadick1 and Sara Schoenfeld4, 1Brigham and Women's Hospital, Boston, MA, 2Harvard Medical School, Boston, MA, 3Mass General Brigham, Boston, MA, 4Massachusetts General Hospital, Boston, MA

    Background/Purpose: Social determinants of health (SDoH) contribute to inequities in rheumatic disease care and outcomes. Most SDoH screening occurs in primary care where resources may…
  • Abstract Number: 1851 • ACR Convergence 2023

    Healthcare Providers’ Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar

    Chiara Gasteiger1, Maria Lobo2, Lun Shen Wong1, Rachel Murdoch1 and Nicola Dalbeth1, 1University of Auckland, Auckland, New Zealand, 2Department of Rheumatology, Te Toka Tumai Auckland, Auckland, New Zealand

    Background/Purpose: Transitioning patients with rheumatic diseases to biosimilars has become common to reduce healthcare costs and improve patient access to biologic therapies. However, it is…
  • Abstract Number: 2523 • ACR Convergence 2023

    Region, Race, and Hospital Factors Impact Length of Stay and Hospital Charges Post-primary Total Knee Arthroplasty

    Kranti Rumalla1, Sumanth Chandrupatla2 and Jasvinder Singh2, 1Northwestern School of Medicine, Chicago, IL, 2University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Osteoarthritis (OA) affects nearly 33 million adults in the US and total knee arthroplasty (TKA) is an effective treatment. Outcomes can vary by regional…
  • Abstract Number: 0164 • ACR Convergence 2023

    Development and Validation of a Virtual Musculoskeletal Examination Method for Disease Activity Assessment in Rheumatoid Arthritis Patients

    Sandeep Yadav, Asna Shaikh and C Balakrishnan, P D Hinduja national Hospital and medical Research centre, Mumbai, India

    Background/Purpose: The rapid adaptation of telemedicine in rheumatology practice brings standardization, reliability and legality challenges. Therefore, it is necessary to develop dependable virtual instruments for…
  • Abstract Number: 0755 • ACR Convergence 2023

    Changes in Rheumatology Providers’ Perceptions of Telehealth Appropriateness from 2021 to 2022

    David Leverenz1, Mary Solomon2, Ricardo Henao2, Isaac Smith3, Catherine Howe4, Nicoleta Economou-Zavlanos5, Bhargav Adagarla6, Theresa Coles7, AJ Overton8, Jayanth Doss9 and Megan Clowse10, 1Duke University School of Medicine, Durham, NC, 2Duke University, Department of Biostatistics, Durham, NC, 3Duke University, Department of Medicine-Rheumatology and Immunology, Durham, NC, 4New York University, New York, NY, 5Duke AI Health, Durham, NC, 6Duke University Clinical Research Institute, Durham, NC, 7Duke University, Department of Population Health Sciences, Durham, NC, 8Consultant, Durham, NC, 9Duke University, Durham, NC, 10Duke University, Chapel Hill, NC

    Background/Purpose: Telehealth in rheumatology rapidly expanded in the wake of the COVID-19 pandemic, however it remains unknown how provider perceptions of telehealth changed as the…
  • Abstract Number: 1095 • ACR Convergence 2023

    Engagement with the RISE Registry Clinician Dashboard Is Associated with Higher Performance on Rheumatology Quality Measures

    Emma Kersey1, Jing Li1, Julia Kay1, Julia Adler-Milstein1, Jinoos Yazdany2 and Gabriela Schmajuk3, 1University of California San Francisco, San Francisco, CA, 2University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA, 3UCSF / SFVA, San Francisco, CA

    Background/Purpose: The American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) EHR-based registry facilitates quality measure calculation and reporting for rheumatology practices in national…
  • Abstract Number: 1854 • ACR Convergence 2023

    What Is Our Regional Delay to Diagnosis in Patients with Axial Spondyloarthropathy – Are We Hitting the Target? Data from a Multi-centre UK Patient Cohort

    Gurdeep Dulay1, Antoni Chan2, Catherine Boys3, Aisling Coy4, Mary Devin5, Leslie Goh6, Arran McDougall2, Kathryn Rigler2, Jacqui Tomkins7, Dinny Wallis7 and Emma Williams8, 1Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom, 2Royal Berkshire NHS Foundation Trust, Reading, United Kingdom, 3NHS, Basingstoke, United Kingdom, 4Salisbury NHS Foundation Trust, Salisbury, United Kingdom, 5Dorset County Hospital NHS, Dorchester, United Kingdom, 6NHS, Portsmouth, United Kingdom, 7NHS, Southampton, United Kingdom, 8NHS, Winchester, United Kingdom

    Background/Purpose: Due to the insidious onset of axial spondyloarthritis (AxSpA), there is often a significant delay to diagnosis. The average delay to diagnosis in the…
  • Abstract Number: 0165 • ACR Convergence 2023

    Hypothyroidism Is Associated with Worse Clinical and Utilization Outcomes After Primary Total Knee Arthroplasty

    Sumanth Chandrupatla1, Kranti Rumalla2 and Jasvinder Singh1, 1University of Alabama at Birmingham, Birmingham, AL, 2Northwestern School of Medicine, Chicago, IL

    Background/Purpose: Limited information is available regarding how medical comorbidities affect the outcomes of total knee arthroplasty (TKA). The association of medical comorbidities with post-TKA outcomes…
  • Abstract Number: 0805 • ACR Convergence 2023

    De-escalation of Anti-TNFs in Older Adults with Rheumatoid Arthritis

    Jiha Lee1, Navasuja Kumar1, Mohammed Kabeto1, Andrzej Galecki1, Chiang-Hua Chang1, Namrata Singh2, Raymond Yung3, Una Makris4 and Julie Bynum1, 1University of Michigan, Ann Arbor, MI, 2University of Washington, Bellevue, WA, 3Michigan Medicine, Ann Arbor, MI, 4UT Southwestern Medical Center and Dallas VA, Dallas, TX

    Background/Purpose: Biologic disease modifying anti-rheumatic drugs (bDMARDs) such as anti-tumor necrosis factors(anti-TNFs) improve clinical and radiographic outcomes in rheumatoid arthritis (RA). However, their use is…
  • Abstract Number: 1351 • ACR Convergence 2023

    HPV Vaccination in Adolescent and Young Adult Patients Seen in an Academic Rheumatology Center

    Caroline Siegel1, Lauren Robinson1, Deanna Jannat-Khah1, Avi Mikhaylov1, Nancy Pan1 and Lisa Sammaritano2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Adolescent and young adults (AYAs) with rheumatic disease (RD) may face disproportionate risk of HPV and associated cancers due to immune dysregulation, immunosuppression and…
  • Abstract Number: 1855 • ACR Convergence 2023

    Using a Whole-population Approach to Help Design More Effective and Efficient Healthcare Services for People with Fibromyalgia

    Gary Macfarlane1, Roxanne Cooksey2, Ernest Choy3 and Rosemary Hollick4, 1Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 2Cardiff University, Cardiff, United Kingdom, 3Section of Rheumatology, Cardiff University, Cardiff, United Kingdom, 4University of Aberdeen, Aberdeen, United Kingdom

    Background/Purpose: A large body of evidence has informed, internationally, management recommendations for people with fibromyalgia. However there are very few studies which have examined how…
  • Abstract Number: 0166 • ACR Convergence 2023

    Annual Economic Burden for Patients with Familial Hypophosphatemia in the United States

    Zhiyi Li1, Elizabeth Marchlewicz2, Danae Black2, Hana Schwartz2, Yang Zhao1 and Erik Imel3, 1Kyowa Kirin North America, Bedminster, NJ, 2Merative, Cambridge, MA, 3Indiana University School of Medicine, Indianapolis, IN

    Background/Purpose: Familial hypophosphatemia (FH) is most commonly due to phosphate regulating endopeptidase X-linked (PHEX) gene mutations resulting in renal phosphate wasting, which leads to rickets,…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology